Coil Embolization of Coronary Artery Fistulas
|ClinicalTrials.gov Identifier: NCT00198016|
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : October 17, 2008
|Condition or disease||Intervention/treatment||Phase|
|C14 C14907933 C14907933125 G09330582163324 C14280647250||Device: Coil||Phase 4|
Congenital coronary artery fistula (CAF) can be defined as a direct communication of a coronary artery with a cardiac chamber, great vessel, or other vascular structure, bypassing the myocardial capillary bed.
CAF is an uncommon anomaly, occurring as an incidental finding in 0.1% to 0.2% of coronary angiograms. They are not gender specific. Many patients have symptoms like congestive heart failure, infective endocarditis, myocardial ischemia, or rupture of an aneurismal fistula. Surgical closure of coronary artery fistula was initially reported in 1983 with low rates of morbidity and mortality.
Percutaneous treatment appeared as an alternative to surgery. Transcatheter closure of CAF was first utilized in 1983. Along this years, with experience and improvements in catheterization equipment and occlusion devices, CAF occlusion have been successfully performed using microcoils.
We report our experience in using microcoils to percutaneous treatment of coronary fistulas.
|Study Type :||Observational|
|Official Title:||Coil Embolization of Coronary Artery Fistulas: A Single Centre Experience|
|Study Start Date :||January 2004|
|Estimated Study Completion Date :||August 2005|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00198016
|Santa Cruz, Tenerife, Spain, 38001|
|Study Director:||Zuheir Kabbani, Cardiology||HOSPITEN|